Safety, Efficacy, and Effectiveness of Coronary Sinus Reducer Implantation in Refractory Angina
CSR implantation is safe and feasible and demonstrates promising antianginal efficacy in patients with RA. However, uncertainty in current efficacy findings and susceptibility of effectiveness data to nonphysical influences preclude definitive conclusions about clinical utility, warranting larger placebo-controlled trials.
Authors
- Rasha Al‐Lamee (ORCID: https://orcid.org/0000-0003-3752-5532)
- Shayna Chotai (ORCID: https://orcid.org/0000-0002-6823-7309)
- Christopher Rajkumar (ORCID: https://orcid.org/0000-0002-0086-1113)
- Muhammad Mohsin (ORCID: https://orcid.org/0000-0002-7546-4278)
- Matthew Shun‐Shin (ORCID: https://orcid.org/0000-0002-1179-0867)
- Fiyyaz Ahmed‐Jushuf (ORCID: https://orcid.org/0000-0002-0650-6032)
- Utkarsh Ojha (ORCID: https://orcid.org/0000-0001-6733-3617)
- Florentina Simader (ORCID: https://orcid.org/0000-0002-5329-6525)
- Krzysztof Macierzanka (ORCID: https://orcid.org/0009-0007-9021-4334)
- Michael Foley
Institutions
- Imperial College Healthcare NHS Trust (GB)
- Queen Elizabeth the Queen Mother Hospital (GB)
- Imperial College London (GB)
Publication Details
- Journal
- JACC: Cardiovascular Interventions
- Published
- 2025-08-01
- DOI
- https://doi.org/10.1016/j.jcin.2025.06.012
- Citations
- 5
- Primary Topic
- Pain Management and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 10.95